Surmodics Total Assets 2010-2024 | SRDX

Surmodics total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Surmodics Annual Total Assets
(Millions of US $)
2024 $179
2023 $186
2022 $158
2021 $195
2020 $169
2019 $160
2018 $164
2017 $137
2016 $133
2015 $99
2014 $105
2013 $102
2012 $104
2011 $157
2010 $170
2009 $186
Surmodics Quarterly Total Assets
(Millions of US $)
2024-09-30 $179
2024-06-30 $177
2024-03-31 $183
2023-12-31 $180
2023-09-30 $186
2023-06-30 $189
2023-03-31 $166
2022-12-31 $170
2022-09-30 $158
2022-06-30 $176
2022-03-31 $184
2021-12-31 $185
2021-09-30 $195
2021-06-30 $177
2021-03-31 $177
2020-12-31 $164
2020-09-30 $169
2020-06-30 $166
2020-03-31 $156
2019-12-31 $155
2019-09-30 $160
2019-06-30 $150
2019-03-31 $151
2018-12-31 $151
2018-09-30 $164
2018-06-30 $160
2018-03-31 $163
2017-12-31 $135
2017-09-30 $137
2017-06-30 $132
2017-03-31 $131
2016-12-31 $129
2016-09-30 $133
2016-06-30 $127
2016-03-31 $122
2015-12-31 $112
2015-09-30 $99
2015-06-30 $96
2015-03-31 $91
2014-12-31 $87
2014-09-30 $105
2014-06-30 $101
2014-03-31 $96
2013-12-31 $95
2013-09-30 $102
2013-06-30 $104
2013-03-31 $108
2012-12-31 $108
2012-09-30 $104
2012-06-30 $158
2012-03-31 $154
2011-12-31 $152
2011-09-30 $157
2011-06-30 $173
2011-03-31 $172
2010-12-31 $172
2010-09-30 $170
2010-06-30 $191
2010-03-31 $191
2009-12-31 $191
2009-09-30 $186
2009-06-30 $182
2009-03-31 $182
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.572B $0.126B
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.987B 24.87
Stryker (SYK) United States $136.147B 30.68
Boston Scientific (BSX) United States $130.670B 37.57
EssilorLuxottica (ESLOY) France $110.026B 0.00
Medtronic (MDT) Ireland $102.570B 15.24
Haleon (HLN) United Kingdom $43.909B 28.53
Lonza Group Ag (LZAGY) Switzerland $42.293B 0.00
GE HealthCare Technologies (GEHC) United States $35.376B 18.35
ResMed (RMD) United States $33.995B 27.93
Terumo (TRUMY) Japan $28.800B 40.67
Koninklijke Philips (PHG) Netherlands $23.527B 18.01
Zimmer Biomet Holdings (ZBH) United States $21.064B 13.41
Insulet (PODD) United States $17.996B 71.67
Baxter (BAX) United States $14.756B 9.60
Smith & Nephew SNATS (SNN) United Kingdom $10.838B 0.00
BellRing Brands (BRBR) United States $10.021B 40.32
Bio-Rad Laboratories (BIO) United States $9.125B 31.01
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.392B 14.85
Prestige Consumer Healthcare (PBH) United States $3.886B 19.33
Haemonetics (HAE) United States $3.862B 18.85
ICU Medical (ICUI) United States $3.751B 35.71
Perrigo (PRGO) Ireland $3.510B 10.33
Envista Holdings (NVST) United States $3.103B 23.11
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.894B 18.63
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.605B 30.05
LeMaitre Vascular (LMAT) United States $2.074B 50.41
Green Thumb Industries (GTBIF) United States $1.630B 28.52
AtriCure (ATRC) United States $1.465B 0.00
InMode (INMD) Israel $1.444B 8.68
Maravai LifeSciences Holdings (MRVI) United States $1.371B 0.00
AdaptHealth (AHCO) United States $1.304B 9.32
BioLife Solutions (BLFS) United States $1.211B 0.00
Owens & Minor (OMI) United States $0.973B 7.60
CeriBell (CBLL) United States $0.958B 0.00
Curaleaf Holdings (CURLF) Canada $0.955B 0.00
Phibro Animal Health (PAHC) United States $0.883B 15.58
Evolus (EOLS) United States $0.688B 0.00
Omeros (OMER) United States $0.593B 0.00
VAREX IMAGING (VREX) United States $0.593B 26.15
Capricor Therapeutics (CAPR) United States $0.587B 0.00
Verano Holdings (VRNOF) United States $0.445B 0.00
Cresco Labs (CRLBF) United States $0.429B 0.00
Quanterix (QTRX) United States $0.383B 0.00
ZimVie (ZIMV) United States $0.373B 31.44
Valneva SE (VALN) France $0.353B 0.00
Biote (BTMD) United States $0.313B 6.86
Viemed Healthcare (VMD) United States $0.312B 29.70
Canopy Growth (CGC) Canada $0.295B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.283B 18.95
Sanara MedTech (SMTI) United States $0.276B 0.00
Zynex (ZYXI) United States $0.268B 56.00
High Tide (HITI) Canada $0.237B 98.00
Aurora Cannabis (ACB) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.54
MacroGenics (MGNX) United States $0.200B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Organigram Holdings (OGI) Canada $0.184B 0.00
TerrAscend (TSNDF) Canada $0.181B 0.00
Brainsway (BWAY) Israel $0.169B 89.60
FitLife Brands (FTLF) United States $0.151B 19.04
Jin Medical (ZJYL) China $0.132B 0.00
TriSalus Life Sciences (TLSI) United States $0.110B 0.00
Quipt Home Medical (QIPT) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.092B 0.00
Exagen (XGN) United States $0.083B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.17
InterCure (INCR) Israel $0.061B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.050B 0.00
Cytosorbents (CTSO) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.82
SNDL (SNDL) Canada $0.000B 0.00